Acceleratory effect of Murraya koenigii leaves extracts in atropine induced delayed small intestinal transit involved possible cholinergic innervation in mice

International Journal of PharmTech Research

Volumn 2, Issue 1, 2010, Pages 322-326

  Tembhurne, S V ^a   Sakarkar, D M ^a  

^a Sudhakarrao Naik Institute of Pharmacy   (India)

Author keywords

Atropine; Cholinergic system; Intestinal transit; Murraya koenigii

Indexed keywords

ALCOHOL; ATROPINE; MURRAYA KOENIGII EXTRACT; PETROLEUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; MALE; MOUSE; NONHUMAN; PLANT LEAF;

EID: 77953373717     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Martin, R.F., Flynn, P., (1997), The acute abdomen in the critically ill patient. Surg. Clin. North. Am., 77, 1455-1464.
2. Janseen, P.A.S., Jagenerous, A.H., (1957), New series of potent analysis. J. Pharm. Pharmacol., 6, 38-40.
3. Raiha, I., Sourander, L., (1993), GI motility disorders: diagnostic workup and use of prokinetic therapy. Geriatrics., 48(11), 57-60.
4. Vandenplas, Y., Hauser, B., Salvatore, S., (2004), Current pharmacological treatment of gastroparesis. J. Expert. Opin. Pharmacother., 5, 2251-2254.
5. Horowitz, M., O'Donovan, D., Jones, K.L., Feinle, C., Rayner, C.K., Samsom, M., (2002), Gastric emptying in diabetes: clinical significance and treatment. Diabet. Med., 19, 177-194.
6. Smith, D.S., Ferris, C.D., (2003), Current concepts in diabetic gastroparesis. Drugs., 63, 1339-1358.
7. Perusicova, J., (2004), Gastrointestinal complications in diabetes mellitus. Vnitr. Lek., 50, 338-343.
8. Ghosh, M.N., (2005), Quantitative study of antagonists on isolated preparations. In: Ghosh MN, ed. Fundamentals of experimental pharmacology. 3rd ed. Kolkata, Hilton & Company, pp. 134-147.
9. Donoso, M.V., Carvajal, A., Paredes, A., Tomic, A., Koenig, C.S., Huidobro-Toro, J.P., (2002), Alpha2-Adrenoceptors control the release of noradrenaline but not neuropeptide Y from perivascular nerve terminals. Peptides.,23, 1663-1671.
10. Kiso, T., Ito, H., Miyata, K., Kamato, T., Naitoh, Y., Iwaoka, K., Yamaguchi, T., (2001), A novel 5-HT3 receptor agonist, YM-31636, increases gastrointestinal motility without increasing abdominal pain. Eur. J. Pharmacol., 431, 35-41.
11. Nagakura, Y., Naitoh, Y., Kamato, T., Yamano, M., Miyata, K., (1996), Compounds possessing 5-HT3 receptor antagonistic activity inhibit intestinal propulsion in mice. Eur. J. Pharmacol., 311, 67-72.
12. Gutstein, H.B., Akil, H., (2006), Opioid analgesics. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's The pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill Companies, Inc, pp. 547-590.
13. Sternini, C., Patierno, S., Selmer, I.S., Kirchgessner, A., (2004), The opioid system in the gastrointestinal tract. Neurogastroenterol. Motil., 16, 3-16.
14. Ramaswamy, S., Rajasekaran, M., Bapna, J.S., (1986), Role of calcium in prolactin analgesia. Arch. Int. Pharmacodyn. Ther., 283, 56-60.
15. Amos, S., Binda, L., Kunle, O.F., Okafor, I., Emeje, M., Akah, P.A., Wambebe, C., Gamaniel, K., (2003), Smooth muscle contraction induced by Indigofera dendroides leaf extracts may involve calcium mobilization via potential sensitive channels. Phytother. Res., 17, 792-796.
16. Macht, D.I., Barbara, G.J., (1931), Two new methods for pharmacological comparison of insoluble purgative. J. Am. Pharm. Sci. Edu., 20, 558.
17. Kamm, M.A., (2000), Why the enteric nervous system is important to clinicians. Gut. 47 Suppl 4: iv8- iv9; discussion iv10.
18. DiTullio, N.W., Cieslinski, L., Matthews, W.D., Storer, B., (1984), Mechanisms involved in the hyperglycemic response induced by clonidine and other alpha-2 adrenoceptor agonists. J. Pharmacol. Exp. Ther., 228, 168-173.
19. Brown, J.H., Taylor, P., (2006), Muscarinic receptor agonists and antagonists. In: Brunton, L.L., Lazo, J.S., Parker, K.L., eds. Goodman & Gilman's The Pharmacological basis of therapeutics. 11th ed, New York, McGraw-Hill Companies, Inc, pp. 183-200.